The update reflects long-term clinical trial data showing that many patients with mCSCC or laCSCC experienced lasting responses
Call it a ray of hope for those enduring the pain of knee osteoarthritis -- the most common form of arthritis, affecting over 300 million people worldwide
Clinical trials found that 77% of patients went into remission after receiving obe-cel
Itvisma is a one-time, fixed-dose therapy designed to tackle the genetic root cause of SMA
The therapy -- Ryoncil (remestemcel-L-rknd) -- will be tested in adults with severe steroid-refractory acute graft-versus-host disease
These initiatives will harness top scientific talent and advanced AI technologies to develop new ways to slow the rise of drug-resistant infections
Innovent plans to soon submit a new drug application (NDA) to China’s National Medical Products Administration
AGA affects up to 80 per cent of men across their lifetime and remains one of the most common and most psychologically challenging forms of hair loss
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide with over 82 million Americans living with CVD
The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
Subscribe To Our Newsletter & Stay Updated
